Liabilities / Assets
22nd percentile
Higher debt load relative to assets than 22% of similar nonprofits.
990 • Fiscal year 2023 • EIN 46-0481876
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
22nd percentile
Higher debt load relative to assets than 22% of similar nonprofits.
Liabilities / Revenue
89th percentile
Higher debt load relative to revenue than 89% of similar nonprofits.
Net Margin
4th percentile
Higher net margin than 4% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
68th percentile
Faster asset growth than 68% of similar nonprofits.
Revenue Growth
8th percentile
Faster revenue growth than 8% of similar nonprofits.
Assets
Up$81,948,557
Up $8,843,640 (+12%) from 2022
Net Assets
Up$77,342,877
Up $4,539,526 (+6.2%) from 2022
Liabilities
Up$4,605,680
Up $4,304,114 (+1427%) from 2022
Revenue
Down$1,586,292
Down $937,294 (-37%) from 2022
Expenses
Up$2,508,519
Up $229,998 (+10%) from 2022
Net Income
Down-$922,227
Down $1,167,292 (-476%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The biotechnology greenhouse of southeastern pennsylvania was established with funds from the commonwealth of pennsylvania's share of the national tobacco settlement to accelerate growth of the life sciences industry by transforming the southeast pennsylvania region's strength in biomedical research and development into commercial opportunities. Approximately $25 million of the original government grant funding has been dedicated for pre-seed or "gap" funding for promising therapeutic, biomedical device and related technology companies, in a program called the greenhouse fund. The greenhouse fund is designed to move promising scientific projects out of the laboratory and into commercial opportunities. Additional funds were set aside for initiatives to increase the region's strengths in biomedical informatics and clinical trials.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
Similar nonprofits based on the same Siviq industry and scale cohort. 2023 filings • 501(c)3 • $50M-$100M nonprofits
Rock Cave, WV
View Organization501(c)3
Revenue vs current organization
5066% higherAssets vs current organization
17% lowerWildwood, FL
View Organization501(c)3
Revenue vs current organization
5067% higherAssets vs current organization
82% lowerWashington, DC
View Organization501(c)3
Revenue vs current organization
873% higherAssets vs current organization
About the sameOmaha, NE
View Organization501(c)3
Revenue vs current organization
13% higherAssets vs current organization
About the same